Eckert & Ziegler to serve as European contract manufacturer for Telix's Phase III study

Eckert & Ziegler signed a multi-year agreement with Telix Pharmaceuticals to serve as the European contract manufacturing organization for Telix's ProstACT GLOBAL Phase III study, supplying Lu-177 from its Berlin facility.

“Eckert & Ziegler will serve as the European contract manufacturing organization (CMO) for Telix's ProstACT GLOBAL Phase III study.”lesechos-comfi.lesechos.fr

• 1 source
• lesechos-comfi.lesechos.frEckert & Ziegler Strahlen- Und Medizintechnik AG (ETR:EUZ) |Eckert, Ziegler Strahlen- Und Medizintechnik AGAug 13, 2024

Summarized from public sources; check the original articles before acting on it.